AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Clinical Trial Uses Bioactive Lipids As Diagnostic Blood Test.(Atairgin Technologies Inc. develops ovarian cancer test)
2001 AUG 23 - (NewsRx Network) -- Atairgin Technologies, Inc. announced that it has completed patient accrual for its U.S. clinical trial designed to evaluate a promising diagnostic marker, bio active lipids, for detection of ovarian cancer.
Ovarian cancer claims more lives in the U.S. than any other gynecologic malignancy, in part because there is currently no reliable diagnostic tool. The primary objective of the trial is to use Atairgin's lipid assay to confirm the presence of an ovarian malignancy in women with a suspicious pelvic mass. Atairgin expects to complete the sample testing and statistical analysis phases of the trial in the third quarter of 2001 and intends to submit the PMA (premarket approval) application to the U.S. Food and Drug Administration (FDA) by year end.
Seven institutions have participated in patient enrollment: Cedars-Sinai Medical Center, Los Angeles, ...
- Atairgin Technologies Names Nationally Known Ovarian Cancer Expert to Clinical...
- Press release article from: PR Newswire February 2, 2000 700+ words
...PRNewswire/ -- Atairgin Technologies, Inc. today...detecting ovarian cancer. Dr. Karlan...officer of Atairgin Technologies. "Together...efforts." "Ovarian cancer continues...detecting ovarian cancer. Atairgin Technologies, founded...
- Atairgin Technologies to Begin Patient Enrollment with LPA Ovarian Cancer Blood...
- Press release article from: PR Newswire February 7, 2000 700+ words
...7 /PRNewswire/ -- Atairgin Technologies, Inc. today announced...present in the blood of ovarian cancer patients. Researchers...detect ovarian disease. Ovarian cancer causes more deaths than...die from the disease. Atairgin Technologies, founded in 1996, is...
- Atairgin Technologies Names Financial Industry Veteran Susan Foley to Board of...
- Press release article from: PR Newswire June 6, 2000 700+ words
...executive officer of Atairgin Technologies. "Her breadth of...early detection of ovarian cancer. Ovarian cancer is the fifth most common...means for detecting ovarian cancer. Atairgin Technologies, founded in 1996...
- Atairgin Technologies Participates in Donation Program With Gynecologic Cancer...
- Press release article from: PR Newswire June 1, 2000 700+ words
...PRNewswire/ -- Atairgin Technologies, Inc. today announced...executive officer of Atairgin Technologies. "Through matching...means for detecting ovarian cancer. Atairgin Technologies, founded in 1996...
- Atairgin Technologies Relocates to Irvine, California.
- Press release article from: PR Newswire June 8, 1999 700+ words
...Pullman. Atairgin Technologies currently...applications. Atairgin Technologies has developed...assay for ovarian cancer based on...onset of ovarian cancer, thereby...possible. Atairgin Technologies, founded...
- Atairgin Technologies Secures $3 Million Investment; Company Appoints Board...
- Press release article from: PR Newswire June 10, 1999 700+ words
...PRNewswire/ -- Atairgin Technologies, Inc. today...officer of Atairgin Technologies. Atairgin...assay for ovarian cancer based on...onset of ovarian cancer, thereby...University. Atairgin Technologies, founded...
- Atairgin Technologies Announces Executive Appointments.
- Press release article from: PR Newswire August 18, 2000 700+ words
...18 /PRNewswire/ -- Atairgin Technologies, Inc. today announced...ever blood test to diagnose ovarian cancer, which we anticipate submitting...FDA early next year." Atairgin Technologies, founded in 1996, is a...
- Atairgin Technologies Presents at Emerging Medical Technologies Conference.
- Press release article from: PR Newswire October 4, 1999 700+ words
...PRNewswire/ -- Atairgin Technologies, Inc...early stage ovarian cancer at the Emerging...diagnosed with ovarian cancer. Currently...breast and ovarian cancer does not...market needs. Atairgin Technologies is an emerging...